CordenPharma Expands Peptide Platform with Greenfield Facility Construction in Switzerland
The company's ambitious expansion plans are set to propel its Peptide Platform business beyond the EUR 1 billion sales milestone by 2028, reinforcing CordenPharma's position as a market leader in integrated supply of small to large-scale services from APIs to Drug Products, for both Injectable and Oral Peptides.
CordenPharma | 07/03/2025 | By Aishwarya | 252
WACKER & CordenPharma Enter Pandemic Readiness State for Germany
WACKER and CordenPharma have officially entered the pandemic readiness state as of June 1, 2024.
CordenPharma | 25/06/2024 | By Aishwarya | 267
CordenPharma Announces Partnership with Certest
CordenPharma has signed a collaboration agreement with Certest, a Spanish company focused on the development of new products with special emphasis in Drug Delivery with LNPs and API synthesis.
CordenPharma | 07/06/2024 | By Aishwarya | 240
CordenPharma, GENEPEP Celebrate Strong Alliance for Developing Peptide Drug Substance
CordenPharma and GENEPEP have recently celebrated one year of their fruitful collaboration.
CordenPharma | 20/04/2024 | By Aishwarya | 433
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy